Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Prentice

Showing results (251-260 of 299) with videos related to

Pageof 30
Sort By:
Blood|May 1, 1991
Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cellsP Oblakowski, C Bello-Fernandez, J E Reittie, et al.
Blood|March 15, 1991
Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell functionC Bello-Fernandez, C Bird, H E Heslop, et al.
Leukemia|September 1, 1989
Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemiaB Simonsson, A K Burnett, H G Prentice, et al.
Lancet (London, England)|March 3, 1984
Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipientsH G Prentice, H A Blacklock, G Janossy, et al.
Leukemia|October 6, 2001
Heterogeneity of VH-JH gene rearrangement patterns: an insight into the biology of B cell precursor ALLI Moreira, M Papaioannou, F Y Mortuza, et al.
Blood|October 25, 2001
Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiationD T Jones, K Ganeshaguru, A E Virchis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1993
Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experienceP H McWhinney, C C Kibbler, M D Hamon, et al.
British Journal of Haematology|February 13, 2001
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyR Chopra, J D Eaton, A Grassi, et al.
Annals of Hematology|March 4, 2003
Immunotherapy for Hodgkin's diseaseC M Rooney, C Bollard, M H Huls, et al.
Lancet (London, England)|April 4, 1987
Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infectionsJ P Grob, J E Grundy, H G Prentice, et al.
Pageof 30

Showing results (251-260 of 299) with videos related to

Sort By:
Pageof 30
Blood|May 1, 1991
Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cellsP Oblakowski, C Bello-Fernandez, J E Reittie, et al.
Blood|March 15, 1991
Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell functionC Bello-Fernandez, C Bird, H E Heslop, et al.
Leukemia|September 1, 1989
Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemiaB Simonsson, A K Burnett, H G Prentice, et al.
Lancet (London, England)|March 3, 1984
Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipientsH G Prentice, H A Blacklock, G Janossy, et al.
Leukemia|October 6, 2001
Heterogeneity of VH-JH gene rearrangement patterns: an insight into the biology of B cell precursor ALLI Moreira, M Papaioannou, F Y Mortuza, et al.
Blood|October 25, 2001
Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiationD T Jones, K Ganeshaguru, A E Virchis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1993
Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experienceP H McWhinney, C C Kibbler, M D Hamon, et al.
British Journal of Haematology|February 13, 2001
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyR Chopra, J D Eaton, A Grassi, et al.
Annals of Hematology|March 4, 2003
Immunotherapy for Hodgkin's diseaseC M Rooney, C Bollard, M H Huls, et al.
Lancet (London, England)|April 4, 1987
Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infectionsJ P Grob, J E Grundy, H G Prentice, et al.
Pageof 30